Infective endocarditis caused by Lactococcus lactis subsp. lactis and Pediococcus pentosaceus: A case report and literature review

Medicine (Baltimore). 2018 Dec;97(50):e13658. doi: 10.1097/MD.0000000000013658.

Abstract

Rationale: Lactococcus lactis and Pediococcus pentosaceus are rare pathogens which rarely caused infections in humans. Several cases with L. lactis endocarditis have been reported in the literature, among them few were caused by L. lactis subsp. Lactis. Opportunistic P. pentosaceus infections were rarely reported.

Patient concerns: A 66-year-old man presented to our hospital due to persistent fever for 15 days. A physical checking revealed a grade II holosystolic murmur at the heart apex. A chest computed tomography (CT) scan suggested bronchitis. L. lactis subsp. lactis was identified in blood cultures. Transthoracic and transesophageal echocardiography revealed the presence of a large hyperechogenic mass in the left atrium, and a large floating vegetation on the mitral valve with a severe mitral regurgitation.

Diagnosis: Infectious endocarditis caused by L. lactis subsp. Lactis was diagnosed.

Interventions: Levofloxacin (0.5 g/day) was used for 20 days; however, L. lactis subsp. lactis remained to be isolated from blood culture. Therefore, vancomycin (2 g/day) was used to replace levofloxacin. Six days after the treatment with vancomycin, the blood culture revealed no L. lactis subspecies lactis, but yielded a growth of gram-positive and non-spore forming cocci; and P. pentosaceus was identified. Antimicrobial susceptibility test revealed P. pentosaceus was sensitive to penicillin and levofloxacin. Vancomycin was discontinued, and levofloxacin (0.5 g/day) was restarted and treated for another 7 days. The patient recovered with negative blood culture results, and discharged from the hospital.

Outcomes: The patient recovered with negative blood culture results, and discharged from the hospital.

Lessons: Our patient had a long-period of antibiotic treatment with strategy alterations. Standard interpretation criteria of Clinical and Laboratory Standards Institute (CLSI) for L. lactis should be established, and molecular tests will increase the identification rate of L. lactis infections.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Endocarditis / diagnostic imaging
  • Endocarditis / drug therapy
  • Endocarditis / microbiology*
  • Endocarditis / pathology
  • Endocarditis, Bacterial / diagnostic imaging
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / microbiology*
  • Endocarditis, Bacterial / pathology
  • Humans
  • Lactococcus lactis / drug effects
  • Lactococcus lactis / isolation & purification*
  • Levofloxacin / administration & dosage
  • Levofloxacin / therapeutic use
  • Male
  • Mitral Valve / diagnostic imaging
  • Mitral Valve / microbiology*
  • Mitral Valve / pathology
  • Pediococcus pentosaceus / drug effects
  • Pediococcus pentosaceus / isolation & purification*
  • Treatment Outcome
  • Vancomycin / administration & dosage
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Levofloxacin
  • Vancomycin